| NDC Code | 45802-230-89 |
|---|
| Package Description | 18 BLISTER PACK in 1 CARTON (45802-230-89) > 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
|---|
| Product NDC | 45802-230 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Guaifenesin And Pseudoephedrine Hydrochloride Extended Release |
|---|
| Non-Proprietary Name | Guaifenesin, Pseudoephedrine Hydrochloride |
|---|
| Dosage Form | TABLET, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20160129 |
|---|
| End Marketing Date | 20220228 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA091071 |
|---|
| Manufacturer | Padagis Israel Pharmaceuticals Ltd |
|---|
| Substance Name | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
|---|
| Strength | 600; 60 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
|---|